mTOR is the major cellular regulator for autophagy which is upregulated during KSHV malignancy, exerting autophagic suppression, which is reported to create metabolically weak cancer cells, making them sensitized against targeted therapy (Gremke et al., 2020). This evidence concerns the gene MTOR and cancer.